InVision™ ctDNA liquid biopsy platform to be used to inform therapy following surgery of curative intent Addario Lung Cancer Medical Research Institute (ALCMI), a patient-founded not-for-profit global research consortium, and Inivata, a global clinical cancer genomics company utilizing an industry-leading liquid ...
Read More »Inivata Launches US Clinical Trial of Innovative ctDNA Liquid Biopsy Analysis in Lung Cancer
Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA) analysis to improve personalized healthcare in oncology, today announces the launch of its US clinical validation study (INI-001) in non-small cell lung cancer (NSCLC). ...
Read More »